III Curso Cáncer de Próstata – Intelecto FSFB – Fundación Santa Fe de Bogotá

AUA 2022 Ga PSMA PET CT for preoperative Lymph Node Staging of High Risk Prostate Cáncer

AUA 2022 Ga PSMA PET CT for preoperative Lymph Node Staging of High Risk Prostate Cáncer

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

ESMO 2022 Duration of Androgen Deprivation Therapy with Post Operative

ESMO 2022 Duration of Androgen Deprivation Therapy with Post Operative

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

ESMO 2022 How Should PET Detected Oligorecurrent Prostate Cancer Best Be Treated

ESMO 2022 How Should PET Detected Oligorecurrent Prostate Cancer Best Be Treated

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

Estudios ARASENS ASCO GU 2022

Estudios ARASENS ASCO GU 2022

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

How can treatment be Individualized by using Genomic Classifiers

How can treatment be Individualized by using Genomic Classifiers

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

Management of cN1 Prostate Cáncer

Management of cN1 Prostate Cáncer

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

PSMA PET CT for staging and monitoring of advanced prostate cáncer

PSMA PET CT for staging and monitoring of advanced prostate cáncer

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

Theragnostics Ca Próstata 2022 Julián Gilberto Rojas Camacho

Theragnostics Ca Próstata 2022 Julián Gilberto Rojas Camacho

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

ESMO 2022 How Should PET Detected Oligorrecurrent Prostate Cancer Best Be Trated

ESMO 2022 How Should PET Detected Oligorrecurrent Prostate Cancer Best Be Trated

Posted on 19 noviembre, 2022

III Curso Cáncer de Próstata

Background